You are here: Industry Insights > Market News > Japan’s cabinet approves plan for free COVID-19 vaccines

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

water filter

WATER FILTER FOR WATER PURIFIER

DUST BAG

Small dust filter

HUMIDIFIER FILTER

Oil fume adsorption filter

Japan’s cabinet approves plan for free COVID-19 vaccines

expresspharmaOctober 29, 2020

Tag: Japan , COVID-19 vaccine , coronavirus

Favorites

Japan’s cabinet approved a plan on Tuesday to use public funds to provide novel coronavirus vaccines to the public for free.

The plan also calls for the government to bear the cost of any health damage caused by a vaccine, according to a document posted on the health ministry’s website.

Prime Minister Yoshihide Suga has pledged to provide enough vaccines for the coronavirus for the public by mid-2021.

Japan has struck deals for hundreds of millions of doses from companies including AstraZeneca and Pfizer.

Previous:Russia applies for WHO emergency use tag for its COVID-19 vaccine

Next:PMI announces Medicago to supply up to 76 mn doses of its plant-derived COVID-19 vaccine candidate

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Japan’s cabinet approves plan for free COVID-19 vaccines | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Japanese Pagodatree Flower-bud

Organic Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Matcha Tea Powder

Desiccant use Japanese Paper

Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract

American standard Japanese standard German standard gate valve

Desiccants use Japanese papaer

Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract Rotundine

Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Organic Matcha Tea Powder

Gallic acid Japanese enterprise standard

PHENOXYMETHYL PENICILLIN POTASSIUM

Japan’s cabinet approves plan for free COVID-19 vaccines

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>